Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT

Inclusion Criteria:

1. Age > 18 years on the day of informed consent

2. History of pathologically confirmed squamous cell carcinoma (or histologic variant)of the oral cavity, pharynx, larynx, nose/paranasal sinuses, carcinoma of a major orminor salivary gland, or cutaneous malignancy of the face or neck

3. History of curative intent surgery with or without adjuvant therapy, with or withoutreconstruction

4. Completion of oncologic treatment within 12 months of study enrollment (but nosooner than 6 weeks post-treatment completion)

5. Patients who complete definitive HNC-directed therapy (e.g., surgery orradiation therapy) but are on adjuvant immunotherapy are considered eligible

6. Oncologic treatment refers to cancer-directed therapy; non-cancer surgery (e.g., trachea-esophageal puncture, flap debulking, etc) are not relevant forthe purposes of determining eligibility vis a vis completing oncologictreatment within 6-week to 12 months of enrollment

7. Cancer-free at the time of accrual

-patients with known indolent malignancies (e.g., non-melanoma skin cancer, low riskthyroid cancer, untreated prostate cancer, etc) would not exclude a patient from thestudy

6. No planned significant HNC ablative or reconstructive surgery (defined by apostoperative inpatient stay of at least three days) during the study interventionor follow-up period as determined by the HNC oncologic surgeon at the time of studyaccrual

7. Willingness to be randomized to either BRIGHT or AC

8. IMAGE-HN score ≥ 22

Exclusion Criteria:

1. Inability to speak or read English

2. Pre-existing, ongoing psychotherapy services for any disorder and the participant isnot willing to discontinue the prior therapy for the duration of the proposed trial

3. Severe mental illness that would prevent trial participation